Need for individualized counseling regarding psoriasis systemic therapy in women of childbearing age: analysis of the PsoFem study at the University Medical Center Hamburg
For WoCBA with childbearing wishes, tumor necrosis factor alpha blockers were most frequently prescribed, in accordance with current guidelines/recommendations. Decision-making for continuing or changing systemic therapy during pregnancy must take into account medication specificities and the vulnerable stages in pregnancy, as well as the limited amount of pregnancy-compatible drugs.
Authors
- Matthias Augustin (ORCID: https://orcid.org/0000-0002-4026-8728)
- Brigitte Stephan (ORCID: https://orcid.org/0000-0001-6127-3692)
- Nomun Ganjuur (ORCID: https://orcid.org/0000-0003-4327-4936)
- Neuza Silva
- Rachel Sommer (ORCID: https://orcid.org/0000-0002-3080-497X)
Institutions
- Universität Hamburg (DE)
- University Medical Center Hamburg-Eppendorf (DE)
Publication Details
- Journal
- International Journal of Women’s Dermatology
- Published
- 2024-11-15
- DOI
- https://doi.org/10.1097/jw9.0000000000000187
- Primary Topic
- Pregnancy and Medication Impact
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Deutsche Forschungsgemeinschaft
- Universitätsklinikum Hamburg-Eppendorf